Glutamatergic dysfunction has been suggested to play an important role in the pathogenesis of hepatic encephalopathy (HE) in acute liver failure (ALF). Increased extracellular brain glutamate concentrations have consistently been described in different experimental animal models of ALF and in patients with increased intracranial pressure due to ALF. High brain ammonia levels remain the leading candidate in the pathogenesis of HE in ALF and studies have demonstrated a correlation between ammonia and increased concentrations of extracellular brain glutamate both clinically and in experimental animal models of ALF. Inhibition of glutamate uptake or increased glutamate release from neurons and/or astrocytes could cause an increase in extracellular glutamate. This review analyses the effect of ammonia on glutamate release from (and uptake into) both neurons and astrocytes and how these pathophysiological mechanisms may be involved in the pathogenesis of HE in ALF.
INTRODUCTION

Acute Liver Failure
Acute liver failure (ALF) resulting from viral infections or toxic liver injury is a lifethreatening condition. Hepatic encephalopathy (HE) and brain edema are serious neurological complications of ALF, which must be treated promptly, ideally by a liver transplantation. HE in ALF progresses through altered mental status to stupor and coma within hours or days. Seizures and hyperexcitability are not uncommon. Mortality rates are high in ALF and death most frequently results from brainstem herniation due to increased intracranial pressure as a result of cytotoxic brain edema. The pathophysiologic mechanisms underlying the precise cause of HE and brain edema in ALF remain largely unknown. However, ammonia remains the leading candidate in the pathogenesis of ALF.
Ammonia in ALF
Hyperammonemia is a consistent finding in experimental animal models of ALF resulting from hepatectomy, hepatic devascularization, or toxic liver injury, and in all cases, Rose severe HE and brain edema are observed. A positive correlation has been reported between arterial ammonia concentrations and the appearance of brainstem herniation in patients with ALF (Clemmensen et al., 1999) . In experimental animal models of ALF, brain ammonia levels may reach concentrations as high as 5 mM (Swain et al., 1992a) , concentrations known to result in deleterious effects, by both direct and indirect mechanisms, on cerebral metabolism and neurotransmission. The importance of ammonia in ALF is emphasized and demonstrated in studies where ammonia-lowering strategies were shown to be beneficial in the prevention of brain edema and severe HE in rats with ALF (Cordoba et al., 1999; Rose et al., 1999 Rose et al., , 2000 . In the present review article, "ammonia" will be used to represent the sum of ammonium ions (NH 4 + ) and ammonia (NH 3 ) unless a distinction is made.
THE GLUTAMATE SYSTEM Glutamate Release and Uptake
Glutamate is the principle excitatory neurotransmitter in the brain. Figure 1 demonstrates a simplified schematic representation of the steps that occur at the glutamate synapse. Glutamate is synthesized in the presynaptic nerve terminal via the enzyme glutaminase and stored in synaptic vesicles, which eventually dock with the presynaptic neuronal membrane and release glutamate into the synaptic cleft by a calcium-dependent mechanism. Released glutamate binds to and activates receptors (ionotropic and metabotropic) both on the postsynaptic neuron and the neighboring astrocyte. Situated on the postsynaptic neuron are ionotropic receptors: N-methyl-D-aspartate (NMDA), α-amino-3-hydro-methyl-4-isoxasole-propionic acid (AMPA) and kainate, all ion channel-gated receptors. Also on the postsynaptic neuron are metabotropic receptors, which are not ion-gated receptors but are instead coupled to calcium dependent second messenger systems. On the neighboring astrocyte, AMPA, kainate, and metabotropic receptors are found. Released glutamate is removed from the extracellular space by high-affinity Na + -dependent transporters located both on astrocytes and neurons. GLT-1 and GLAST, more commonly referred to as, EAAT-2 and EAAT-1 respectively, are located on astrocytes. EAAT-3 is found on neurons, away from the presynaptic cleft and is, therefore, thought to play a minor role in glutamate clearance from the synaptic cleft. Glutamate uptake by astrocytes is an important pathway since ammonia removal in brain relies entirely from the synthesis of glutamine by the enzyme glutamine synthetase, found uniquely in astrocytes. The resulting glutamine produced is retransported to the presynaptic nerve terminal as the immediate precursor of the neurotransmitter glutamate, completing the glutamate-glutamine cycle.
Increased Extracellular Brain Glutamate in ALF: Effect of Ammonia
In recent years, the results of several studies have suggested that alterations in glutamatergic synaptic regulation are implicated in the pathogenesis of ALF. Using the technique in vivo cerebral microdialysis, several reports have consistently described increased extracellular concentrations of brain glutamate in different models of experimental ALF (Bosman et al., 1992; de Knegt et al., 1994; Hilgier et al., 1999; Michalak et al., 1996) . It has been suggested that ammonia (directly or indirectly) is causing this increase in extracellular brain glutamate concentrations. A positive correlation has been reported between extracellular brain concentrations of glutamate and arterial ammonia concentrations in acute (ischemic) liver failure in the rat (Michalak et al., 1996) . Furthermore, using mild hypothermia as a treatment in rats with ALF, extracellular brain glutamate concentrations were normalized together with a lowering of brain (cerebrospinal fluid) ammonia (Rose et al., 2000) .
Glutamatergic Dysfunction in ALF
Several studies have demonstrated glutamate receptor changes in brain of animals with ALF.
[ 3 H]-kainate binding sites were significantly reduced in cerebral cortical preparations from galactosamine-treated rabbits with severe encephalopathy (Ferenci et al., 1984) . Similar findings of a significant loss of [ 3 H]-kainate binding sites were subsequently reported in frontal cortex in ischemic liver failure in the rat . In contrast, densities of neuronally localized NMDA binding sites are unchanged in ischemic liver failure in both rabbits (de Knegt et al., 1993) and rats (Michalak et al., 1996) . Furthermore, a selective loss of AMPA receptor binding sites was found in the brains of rats with ischemic liver failure . This selective loss of AMPA sites could be the consequence of exposure of the brains of these animals to increased ammonia concentrations generated in ALF. In support of this possibility, previous studies have demonstrated a selective depression of AMPA currents by exposure of hippocampal pyramidal neurons to 3 mM ammonia (Fan and Szerb, 1993) . In a separate series of electrophysiological studies, millimolar concentrations of ammonia led to a reduction in the degree of depolarization of cerebral cortical preparations by AMPA (Moroni et al., 1995) , suggesting that ammonia has the capacity to modify the structural or functional characteristics of the AMPA receptor.
Therefore, increased extracellular glutamate in the brains of animals with HE in ALF, along with a concomitant loss of AMPA/kainate receptors could result in a relative increase of NMDA receptor-mediated transmission. In support of this theory, the noncompetitive NMDA receptor antagonist, memantine, administered to rats with liver ischemia resulted in significant improvement in clinical grading and less slowing of electroencephalogram activity (Vogels et al., 1997) . These interesting findings support the notion that NMDA receptor activity is one of the characteristics of HE in experimental ALF. Furthermore, NMDA receptor activation has previously been shown to be increased in acute hyperammonemia in the absence of liver failure, and the NMDA receptor antagonist MK-801 was found to afford significant protection in animals administered a lethal injection of ammonia (Marcaida et al., 1991) .
POSSIBLE REASONS FOR INCREASED EXTRACELLULAR BRAIN GLUTAMATE IN ALF Glutamate Release from Neurons
At physiological pH, more than 98% of ammonia is in NH 4 + form, however NH 3 enters cells more readily. The ammonium ion (NH 4 + ) has an ionic radius very similar to K + and has been suggested to enter cells through K + channels. Therefore adding NH 4 + is equivalent to increasing [K + ] e , which subsequently decreases the membrane potential which in turn can be blocked by Ba 2+ , a potassium channel inhibitor. In neurons, ammonia (4 mM) has been demonstrated to lower the membrane potential without altering membrane resistance. This suggests that metabolic factors rather than ion-conductance changes underlie the depolarization. A probable mechanism for the ammonium ion-induced depolarization is the loss of intracellular K + and subsequently an increase in extracellular K + during exposure to NH 4 + , which by reducing the equilibrium potential of K + produces depolarization without altering membrane conductance. However, ammonium ions decrease synaptic transmission mediated by hyperpolarizing Cl − -dependent inhibitory postsynaptic potentials, an effect which results from the inactivation of the extrusion of Cl − from neurons (Raabe, 1989) . Furthermore, ammonium ions depress excitatory synaptic transmission in neurons (Szerb and Butterworth, 1992) . It has been suggested that this depression of excitatory transmission by ammonium ions could be due to less glutamate available presynaptically for release. Glutaminase, found in neurons, produces glutamate plus ammonia from glutamine and subsequently ammonia has shown to inhibit glutaminase (Bradford et al., 1989) . In addition, brain glutamate concentrations are reduced in rats with either acute (ischemic) liver failure or thioacetamide-induced liver damage (Swain et al., 1992b) . Furthermore, postsynaptically, ammonia reduces the effectiveness of released glutamate (Fan et al., 1990 ) through AMPA receptors. Hamberger et al. demonstrated the inhibitory effect of ammonia on glutamate release as 3-5 mM NH 4 Cl reduced potassium evoked glutamate release from hippocampal slices (Hamberger et al., 1979 (Hamberger et al., , 1982 . However, reviewing Fig. 1 from Hamburger et al. (1982) upon initial ammonia application (3 mM), an increase in glutamate release is demonstrated when compared with controls. Therefore, pretreatment with ammonia may reduce potassium stimulated glutamate release. However, glutamate is released in hippocampal slices upon an acute application of ammonia. Overall, ammonia inhibits glutamate synaptic transmission in neurons by (1) inhibiting current gated AMPA receptors postsynaptically and (2) depleting synaptically released glutamate from neurons by inhibiting the glutamate-producing enzyme, glutaminase.
Inhibition of Glutamate Uptake
A great deal of evidence suggests that the increased extracellular brain glutamate in ALF results from an inhibition of glutamate uptake. Exposure of rat hippocampal slices to blood extracts from patients with varying severity of HE resulted in inhibition of D-aspartate uptake and the relative potency of inhibition was found to correlate with ammonia concentrations of the extracts (Schmidt et al., 1990) . Decreased glutamate uptake was described in synaptosomal preparations from rats with experimental ALF (Oppong et al., 1995) . Furthermore, exposure of primary cultured astrocytes to millimolar concentrations of ammonia also resulted in a significant reduction in uptake of [
3 H]-D-aspartate (Bender and Norenberg, 1996) . In extracts from cerebral cortex of rats in coma stages of encephalopathy following hepatic devascularization, a significant loss of GLT-1 (EAAT-2) protein and gene expression was observed (Knecht et al., 1997) . Similar findings were found in the brains of mice with thioacetamide-induced ALF (Norenberg et al., 1997) . Recently, it has been shown that ammonia in concentrations equivalent to those reported in brain of ALF (5 mM), when added to cultured rat cortical astrocytes for 7 days, results in a comparative loss of glutamate uptake and in addition loss of glutamate transporter GLAST (EAAT-1) protein and mRNA (Chan et al., 2000) . Interestingly, EAAT-2 knockout mice manifest brain edema (Tanaka et al., 1997) . Moreover, decreased astrocytic uptake of glutamate could limit ammonia detoxification by brain by limiting the availability of the substrate for glutamine synthetase. In ALF, the temporal development of brain edema is undefined and it is uncertain whether increased extracellular brain glutamate is a cause or an effect of astrocytic swelling. However, it has been demonstrated that a significant increase in extracellular glutamate arises before the development of brain edema (Michalak et al., 1996) . It is ironic that glutamate uptake is inhibited in astrocytes during high toxic ammonia concentrations when glutamate is an important and necessary precursor for glutamine synthetase-the only ammonia removal system in the brain. Recently, Mort et al. (2001) demonstrated that an acute application of ammonia potentiates glutamate uptake in glial cells isolated from salamander retina, suggesting glutamate uptake inhibition may be a later phenomenon in the pathogenesis of HE and brain edema in ALF.
Glutamate Release from Astrocytes
Glutamate can be released from astrocytes by three different mechanisms: two by calcium-independent (reverse glutamate transporter and swelling induced) and one by calcium-dependent mechanisms (vesicular release). The role of ammonia in each of these glutamate release pathways is reviewed hereafter.
Calcium-Independent Glutamate Release
Astrocytic Cell Swelling in ALF. As mentioned previously, brain edema leading to increased intracranial pressure is a fatal consequence of ALF. It has been suggested that ammonia plays an important role in the pathogenesis of brain edema (astrocytic swelling) in ALF. Increased brain water content has been described in both normal (Takahashi et al., 1991) and in portacaval shunted (Blei et al., 1994) rats infused with ammonia as well as in rats with liver devascularization (Rose et al., 1999) . Similar results have been described in vitro following the exposure of cultured astrocytes to ammonia (Norenberg et al., 1991) . Furthermore, prevention of brain edema in rats with ALF has been shown with ammonialowering strategies (Cordoba et al., 1999; Rose et al., 1999 Rose et al., , 2000 . Unrelated to ammonia, swelling-induced glutamate release was demonstrated in cortical astrocytes exposed to a hypo-osmotic medium (Kimelberg et al., 1990) . Ammonia-induced astrocytic swelling has been suggested to result in glutamine accumulation in astrocytes (by glutamine synthetase), possibly because of the inhibition of glutaminase (Bradford et al., 1989) . However, an increase in extracellular brain glutamate could also lead to glutamate-induced astroglial swelling (Hansson et al., 1997) .
Reversed Glutamate Transport. It has been demonstrated that when insufficient energy is available to regulate the membrane potential, glutamate transporters reverse, that is, glutamate transported out of the astrocyte instead of being transported in (Szatkowski et al., 1990) . A fall in ATP levels leads to an inhibition of the Na + /K + pump and therefore a rundown of the transmembrane gradients for [K + ], [Na + ], and voltage. To re-establish the ion and voltage gradients, the glutamate transporters release glutamate, which occurs with the same stoichiometry as forward uptake (i.e., 2 Na + and 1 glutamate anion come out of the cell and 1 K + is transported into the cell). An increase in energy demand occurs upon ammonia application by stimulating glycolysis through activation of phosphofructokinase (Sugden and Newsholme, 1975) , and therefore possibly resulting in the stimulation of cerebral glucose utilization in acutely hyperammonemic animals (Hawkins et al., 1973) . However, applications of NMR spectroscopy studies in rats with hyperammonemia due to ALF could not demonstrate any significant loss of ATP (Bates et al., 1989) . Recently, much evidence has emerged suggesting an inhibition or slow down of energy metabolism in ALF. Ammonia chloride (5 mM) when applied to cultured astrocytes stimulates lactate production and lactate dehydrogenase activity (Bélanger et al., 2001 ). Similar results have been found in CSF of rats at precoma and coma stages with ALF (Chatauret et al., 2001) . Clinically, using in vivo microdialysis techniques, extracellular lactate was found to increase in association with increased intracranial pressure in patients with ALF (Tofteng et al., 2001) . Increase in lactate production indirectly suggests that anaerobic pathways may be stimulated to compensate for a decreased pyruvate oxidation (possibly because of the ammonia inhibition on the enzyme α-ketoglutarate dehydrogenase in the tricarboxylic acid cycle (Lai and Cooper, 1986) ). However, acute ammonia exposure did not reverse glutamate transporters but increased glutamate uptake into astrocytes (Mort et al., 2001) , suggesting that glutamate transporter reversal is not the cause of the initial increase in extracellular glutamate.
Calcium-Dependent Glutamate Release
The role of astrocytes in synaptic transmission is an important new concept for normal brain function. It was originally thought that astrocytes were unresponsive to excitatory neurotransmitters and only neurons could respond with depolarization and excitation. However, in a recent review (Vesce et al., 2001) , the active role of astrocytes in synaptic transmission and its importance in neuron-glia signaling is described. Glutamate released from neurons can bind to its respective receptors (AMPA/kainate and metabotropic) on the astrocyte and trigger [Ca 2+ ] i elevation. Interestingly, astrocytes possess vesicular proteins (e.g. SNARE complex) which are essential in vesicular neurotransmitter release (Araque et al., 2000 (Papura et al., 1994) , KCl (Nicholls and Sihra, 1986) , or more recently ATP (Innocenti et al., 2000; Jeremic et al., 2001) . Furthermore, Pasti et al. (2001) demonstrated that increased cytosolic calcium regulates exocytotic release of glutamate. More specifically, it was further demonstrated that Ca 2+ -dependent release of glutamate was mediated by prostaglandins because cyclooxygenase inhibitors potently inhibited glutamate release (Bezzi et al., 1998) . Lipoxygenase and epoxygenase inhibitors were ineffective and furthermore cyclooxygenase metabolites (prostaglandins) PGD 2 , PGE 2 , and PGF 2α , all induced rapid glutamate release with PGE 2 being the most effective.
Ammonium chloride at concentrations of 5, 10, and 20 mM has been shown to depolarize cultured rat cortical astrocytes and that the sustained depolarization induced by ammonia depended on changes in intracellular ion concentrations rather than changes in ion conductances. Also, ammonia at 5 mM stimulates an increase in [Ca 2+ ] i in cultured astrocytes, using calcium-imaging techniques (Rose and Kettenmann, unpublished data) . Calcium can increase intracellularly by entering the cell from the extracellular space through Ca 2+ voltage-gated channels and/or specific pumps and transporters or can be released from internal stores. Ammonia depolarizes astrocytes and at very high concentrations can open voltage-gated calcium channels when the membrane potential is raised sufficiently high. In addition, ammonia releases calcium from IP3-sensitive intracellular calcium stores in microglia (Minelli et al., 2000) . This has raised the possibility that ammonia can stimulate glutamate release from astrocytes in a Ca 2+ -dependent manner.
SUMMARY
Increased extracellular concentrations of brain glutamate in ALF can result from an increase in glutamate release and/or a decrease in glutamate removal (uptake) both by neurons and/or astrocytes. Glutamate can be released from neurons and astrocytes by cell swelling induced mechanisms, reversal of glutamate transporters, and/or calcium-dependent mechanisms. In neurons, an increase in glutamate release is unlikely to occur because ammonia inhibits glutaminase reducing the amount of glutamate available for synaptic release. Furthermore, cytotoxic edema in ALF develops in astrocytes and not neurons, eliminating the possibility of swelling-induced release of glutamate from neurons. An inhibition of glutamate removal by the high affinity transporters on astrocytes would result in an increase in extracellular brain glutamate concentrations. However, it has been demonstrated in vitro that acute application of ammonia potentiates glutamate uptake into astrocytes (Mort et al., 2001) . Ammonia-induced astrocytic swelling may potentially stimulate glutamate release from astrocytes; however, this would suggest that increased extracellular brain glutamate is the result and not a cause of astrocytic swelling. Interestingly, increased extracellular brain glutamate concentrations precede the onset of brain edema in rats with ALF due to hepatic devascularization (Michalak et al., 1996) . Reversal of glutamate transporters occurs when high-energy phosphates are depleted. Although ATP levels have been found to be unchanged in ALF, increased lactate production has been demonstrated, suggesting an inhibition of glucose oxidation but this appears to arise late in the development of HE in ALF. Astrocytes play an important role in synaptic transmission and under normal physiological conditions are capable of releasing glutamate in a calcium-dependent manner.
There is now increasing evidence that ammonia can stimulate [Ca 2+ ] i leading to stimulation and deregulation of glutamate release. Figure 2 represents a hypothesis that may occur during the development of HE and brain edema in ALF. Ammonia enters neurons and inhibits glutaminase resulting in (1) less glutamate produced and available for release and (2) disruption of the glutamate-glutamine cycle between astrocytes and neurons. Ammonia also inhibits AMPA receptor activation but does not affect NMDA receptors. Overall, ammonia decreases glutamate release from neurons by inhibiting synaptic transmission and decreasing intracellular glutamate. Ammonia also enters astrocytes and (1) is detoxified by glutamine synthetase producing glutamine and (2) stimulates glutamate release in a calcium-dependent manner leading to increased extracellular glutamate. With inhibition of the glutamate-glutamine cycle, glutamine remains "trapped" in the astrocyte resulting in intracellular hypertonicity and cytotoxic swelling. Deregulation of the release of glutamate from astrocytes could also be a factor involved in astrocytic swelling. Once the astrocyte is swollen, glutamate uptake is inhibited to decrease the ion uptake preventing further swelling. Furthermore, inhibition of glutamate uptake and swelling-induced release of glutamate may add to the already increased extracellular concentrations of glutamate. Because NMDA receptors are not affected by ammonia as are the AMPA/kainate receptors, this may explain the seizures and hyperexcitability, not uncommonly seen in patients with ALF.
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